Page 553 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 553
Appendix Table C4.5: Cost comparisons of watchful waiting with active treatments (continued)
Author Design Data Years N Methods Costs WW RP RT Notes
year source Population (95% (95% CI) (95% CI)
UI characteristics CI)
Mean Same as
cumulative above
function cost
over 5.5 yr
Total $ $ 35,037 $ 41,419
31,789 [BT]
$ 56,725
Medication $ 6869 [EBRT]
costs $ 5098
$ 4940 [BT]
$ 9164
Office visit $ 18,180 [EBRT]
costs $
21,757
$ 23,873
Hospitalization $ 9989 [BT]
costs $ 43,327
$ 4934 [EBRT]
[Intermediate
risk patients] $ 12,605
[BT]
$ 4234
[EBRT]
C-194
